Schedule of ratings—infectious diseases, immune disorders and nutritional deficiencies

Description Percentage

For active disease

100

After active disease has resolved, rate at 0 percent for infection. Rate any residual disability of infection within the appropriate body system.

Vibriosis (Cholera, Non-cholera):

Evaluate under the General Rating Formula

Note: Rate residuals of cholera and non-cholera vibrio infections, such as renal failure, skin, and musculoskeletal conditions, within the appropriate body system

Description Percentage

As active disease

100

Note 1: Continue a 100 percent evaluation beyond the cessation of treatment for active disease. Six months after discontinuance of such treatment, determine the appropriate disability rating by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter.  Thereafter, rate under the appropriate body system any residual disability of infection, which includes, but is not limited to liver damage and bone marrow disease.

Note 2: Confirm the recurrence of active infection by culture, histopathology, or other diagnostic laboratory testing.

Description Percentage

As active disease

100

Note: Continue a 100 percent evaluation beyond the cessation of treatment for active disease. Six months after discontinuance of such treatment, determine the appropriate disability rating by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter. Thereafter, rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, skin lesions, peripheral neuropathy, or amputations.

Evaluate under the General Rating Formula.

Note 1: The diagnosis of malaria, both initially and during relapse, depends on the identification of the malarial parasites in blood smears or other specific diagnostic laboratory tests such as antigen detection, immunologic (immunochromatographic) tests, and molecular testing such as polymerase chain reaction tests.

Note 2: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, liver or splenic damage, and central nervous system conditions.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, epididymitis, lymphangitis, lymphatic obstruction, or lymphedema affecting extremities, genitals, and/or breasts.

Description Percentage

Evaluate under the General Rating Formula

100

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, endocarditis or skin lesions.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, liver or spleen damage, iritis, uveitis, or central nervous system involvement.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, heart damage

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, diseases of the nervous system, vascular system, eyes, or ears (see DC 7004, DC 8013, DC 8014, DC 8015, and DC 9301).

Description Percentage

As active disease

100

Note 1: Confirm the recurrence of active infection by culture, histopathology, or other diagnostic laboratory testing.

Note 2: Rate under the appropriate body system any residual disability of infection which includes, but is not limited to, skin conditions and conditions of the respiratory, central nervous, musculoskeletal, ocular, gastrointestinal, and genitourinary systems and those residuals listed in §4.88c.

Description Percentage

As active disease

100

Note 1: Continue the rating of 100 percent for the duration of treatment for active disease followed by a mandatory VA exam. If there is no relapse, rate on residuals. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter.

Note 2: Confirm the recurrence of active infection by culture, histopathology, or other diagnostic laboratory testing.

Note 3: Rate under the appropriate body system any residual disability of infection which includes, but is not limited to, skin conditions and conditions of the respiratory, central nervous, musculoskeletal, ocular, gastrointestinal, and genitourinary systems and those residuals listed in §4.88c.

Description Percentage

Marked mental changes, moist dermatitis, inability to retain adequate nourishment, exhaustion, and cachexia

100
Description Percentage

With all of the symptoms listed below, plus mental symptoms and impaired bodily vigor

60
Description Percentage

With stomatitis, diarrhea, and symmetrical dermatitis

40
Description Percentage

With stomatitis, or achlorhydria, or diarrhea

20
Description Percentage

Confirmed diagnosis with nonspecific symptoms such as: decreased appetite, weight loss, abdominal discomfort, weakness, inability to concentrate and irritability

10

Description Percentage

Marked mental changes, moist dermatitis, inability to retain adequate nourishment, exhaustion, and cachexia

100
Description Percentage

With all of the symptoms listed below, plus mental symptoms and impaired bodily vigor

60
Description Percentage

With stomatitis, diarrhea, and symmetrical dermatitis

40
Description Percentage

With stomatitis, or achlorhydria, or diarrhea

20
Description Percentage

Confirmed diagnosis with nonspecific symptoms such as: decreased appetite, weight loss, abdominal discomfort, weakness, inability to concentrate and irritability

10

Evaluate under the General Rating Formula

Note 1: Culture, serologic testing, or both must confirm the initial diagnosis and recurrence of active infection.

Note 2: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, meningitis, liver, spleen and musculoskeletal conditions.

Rickettsial, ehrlichia, and anaplasma infections:

Evaluate under the General Rating Formula

Note 1: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, bone marrow, spleen, central nervous system, and skin conditions.

Note 2: This diagnostic code includes, but is not limited to, scrub typhus, Rickettsial pox, African tick-borne fever, Rocky Mountain spotted fever, ehrlichiosis, or anaplasmosis.

Evaluate under the General Rating Formula

Note 1: Confirm by culture or other specific diagnostic laboratory tests the initial diagnosis and any relapse or chronic activity of infection.

Note 2: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, arthritis, lung lesions, or meningitis

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, arthritis, Bell's palsy, radiculopathy, ocular, or cognitive dysfunction.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection.

Description Percentage

As active disease

100

Note: Continue the rating of 100 percent through active disease followed by a mandatory VA exam. If there is no relapse, rate on residual disability. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter.

Description Percentage

As acute or asymptomatic chronic disease

0

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, conditions of the liver, intestinal system, female genital tract, genitourinary tract, or central nervous system.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, conditions of the central nervous system, liver, or kidney.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, Guillain-Barre syndrome, reactive arthritis, or uveitis.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, chronic hepatitis, endocarditis, osteomyelitis, post Q-fever chronic fatigue syndrome, or vascular infections.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, reactive arthritis.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, hemolytic-uremic syndrome or reactive arthritis.

Evaluate under the General Rating Formula

Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, variable physical, functional, or cognitive disabilities.

Description Percentage

Acute, with frequent exacerbations, producing severe  of health

100
Description Percentage

Exacerbations lasting a week or more, 2 or 3 times per year

60
Description Percentage

Exacerbations once or twice a year or symptomatic during the past 2 years

10

Note: Evaluate this condition either by combining the evaluations for residuals under the appropriate system, or by evaluating DC 6350, whichever method results in a higher evaluation.

Description Percentage

AIDS with recurrent opportunistic infections (see Note 3) or with secondary diseases afflicting multiple body systems; HIV-related illness with debility and progressive weight loss,

100
Description Percentage

Refractory constitutional symptoms, diarrhea, and pathological weight loss; or minimum rating following development of AIDS-related opportunistic infection or neoplasm

60
Description Percentage

Recurrent constitutional symptoms, intermittent  diarrhea, and use of approved medication(s); or minimum rating with T4 cell count less than 200of AIDS-related

30
Description Percentage

Following development of HIV-related constitutional symptoms; T4 cell count between 200 and 500; use of approved medication(s); or with evidence of depression or memory loss with employment limitations

10
Description Percentage

Asymptomatic, following initial diagnosis of HIV infection, with or without lymphadenopathy or decreased T4 cell count

0

Note 1: In addition to standard therapies and regimens, the term “approved medication(s)” includes treatment regimens and medications prescribed as part of a research protocol at an accredited medical institution.

Note 2: Diagnosed psychiatric illness, central nervous system manifestations, opportunistic infections, and neoplasms may be rated separately under the appropriate diagnostic codes if a higher overall evaluation results, provided the disability symptoms do not overlap with evaluations otherwise assignable above.

Note 3: The following list of opportunistic infections are considered AIDS-defining conditions, that is, a diagnosis of AIDS follows if a person has HIV and one more of these infections, regardless of the CD4 count--candidiasis of the bronchi, trachea, esophagus, or lungs; invasive cervical cancer; coccidioidomycosis; cryptococcosis; cryptosporidiosis; cytomegalovirus (particularly CMV retinitis); HIV-related encephalopathy; herpes simplex-chronic ulcers for greater than one month, or bronchitis, pneumonia, or esophagitis; histoplasmosis; isosporiasis (chronic intestinal); Kaposi's sarcoma; lymphoma; mycobacterium avium complex; tuberculosis; pneumocystis jirovecii (carinii) pneumonia; pneumonia, recurrent; progressive multifocal leukoencephalopathy; salmonella septicemia, recurrent; toxoplasmosis of the brain; and wasting syndrome due to HIV.

Chronic Fatigue Syndrome (CFS):

Chronic fatigue syndrome (CFS) is a muddled issue described by outrageous fatigue that goes on for at any rate a half year and that can't be completely clarified by a hidden ailment. The fatigue deteriorates with physical or mental movement yet doesn't improve with rest.

Some Common Symptoms Include:

  • Rest that isn't reviving
  • Troubles with memory, center and focus
  • Dizziness that deteriorates with dropping from resting or sitting to standing

This condition is otherwise called myalgic encephalomyelitis. The latest term proposed is systematic exertional intolerance disease (SEID).

The reason for chronic fatigue syndrome is obscure, in spite of the fact that there are numerous speculations — going from viral diseases to mental pressure. A few specialists accept chronic fatigue syndrome may be set off by a blend of variables.

There's no single test to affirm an analysis of chronic fatigue syndrome. You may require an assortment of clinical trials to preclude other medical issues that have comparative symptoms. Therapy for chronic fatigue syndrome centers around improving symptoms.

Symptoms

Symptoms of chronic fatigue syndrome can change from individual to individual, and the seriousness of symptoms can vary from every day. Signs and symptoms may include:

  • Fatigue
  • Issues with memory or memory loss
  • Sore throat
  • Migraines
  • Developed lymph hubs in your neck or armpits
  • Unexplained muscle or joint torment
  • Dizziness that deteriorates with dropping from resting or sitting to standing
  • Unrefreshing rest
  • Outrageous fatigue after physical or mental exercise

When Should One See A Specialist?

Fatigue can be a side effect of numerous illnesses, like diseases or mental problems. As a rule, see your primary care physician if you have experienced extreme fatigue.

What Causes Chronic Fatigue Syndrome?

The reason for chronic fatigue syndrome is as yet unclear. A few people might be brought into the world with an inclination for the issue, which is then set off by a blend of components.

  • Viral contaminations
  • Immune system issues.
  • Hormonal imbalance.
  • Physical or passionate injury

Description Percentage

Which are nearly constant and so severe as to restrict routine daily activities almost completely and which may occasionally preclude self-care

100
Description Percentage

Which are nearly constant and restrict routine daily activities to less than 50 percent of the pre-illness level, or; which wax and wane, resulting in periods of incapacitation of at least six weeks total duration per year

60
Description Percentage

Which are nearly constant and restrict routine daily activities to 50 to 75 percent of the pre-illness level, or; which wax and wane, resulting in periods of incapacitation of at least four but less than six weeks total duration per year

40
Description Percentage

Which are nearly constant and restrict routine daily activities by less than 25 percent of the pre-illness level, or; which wax and wane, resulting in periods of incapacitation of at least two but less than four weeks total duration per year

20
Description Percentage

Which wax and wane but result in periods of incapacitation of at least one but less than two weeks total duration per year, or; symptoms controlled by continuous medication

10

Note: For the purpose of evaluating this disability, incapacitation exists only when a licensed physician prescribes bed rest and treatment.

Note: Rate any residual disability of infection within the appropriate body system as indicated by the notes in the evaluation criteria. As applicable, consider the long-term health effects potentially associated with infectious diseases as listed in §3.317(d) of this chapter, specifically Brucellosis, Campylobacter jejuni, Coxiella burnetii (Q fever), Malaria, Mycobacterium Tuberculosis, Nontyphoid Salmonella, Shigella, Visceral Leishmaniasis, and West Nile virus.

Need help with Medical Compensation? If your disability claim is not clearly supported by your medical records along with evidence, your claim can be denied. We have helped thousands of Veterans claim the compensation they deserve.

Get More Info